Schering Names Baxter’s Sabatino As General Counsel
This article was originally published in The Pink Sheet Daily
One of Thomas Sabatino’s top priorities as general counsel will be the ongoing investigations by the Boston and Philadelphia U.S. Attorney’s Offices. Sabatino will succeed Joseph Conners effective April 15.
You may also be interested in...
Surge of interest prompts US FDA to consider how to adjust feedback, including potentially creating a separate team to answer more basic questions.
When the closest you can get to US FDA staff is Webex, the meeting minutes and interactions with the review team project manager take on increased importance, consultants suggest during an Informa-sponsored webinar.
Amid the COVID-19 pandemic, Richard Pazdur doesn’t want the cancer patient forgotten. His solution: keep churning out approvals.